If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
However, these are frequently ineffective and renal replacement therapy (RRT) in combination with high-quality cardiopulmonary resuscitation (HQ-CPR) should be considered. This is especially true if return of spontaneous circulation is not achieved within 15 minutes or with an initial serum potassium ≥9.5 mmol/L.
Both conventional hemodialysis (cHD) and continuous renal replacement therapy (CRRT) have been described with safety and efficiency in hyperkalemic cardiocirculatory arrest (HCA).
Successful treatment of a patient with cardiac arrest due to hyperkalemia by prolonged cardiopulmonary resuscitation along with hemodialysis: A case report and review of the literature.
However, in all case reports describing CRRT it was associated with veno-arterial extracorporeal life support (V-A ECLS) for augmented systemic perfusion.
In hospitals there is great heterogeneity in the availability of either V-A ECLS or cHD equipment, and there may be a tendency to use CRRT because of defibrillation compatibility.
Successful treatment of a patient with cardiac arrest due to hyperkalemia by prolonged cardiopulmonary resuscitation along with hemodialysis: A case report and review of the literature.
we simulated potassium kinetics during a cHD session with a potassium concentration of 9.5 mmol/L at dialysis initiation. For dialysis parameterization we used: (1) blood flow rate (Qb) of 200 cc/min, the average blood flow obtainable in patient in HCA during HQ-CPR with a conventional provisory catheter
; (2) dialysate flow rate (Qd) of 500 mL/min, the normal dialysate flow; and (3) potassium dialysate concentration of 2 mmoL/L, the lowest readily available concentration.
We then simulated potassium kinetics during CRRT sessions. We considered a multiFiltratePRO machine with an AV1000 filter in continuous venovenous hemodialysis (CVVHD) mode with: (1) Qb of 200 cc/min; (2) Qd of 4.800 cc/h, the maximum flow rate of the equipment maintaining a Qb/Qd ratio of 2.5 which allows a near-complete saturation of the dialysate; and (3) potassium dialysate concentration of 0 mmoL/L which is the lowest commercially available concentration. Finally, we tested a continuous venovenous hemodiafiltration (CVVHDF) by adding a replacement fluid with a 0 mmoL/L potassium dialysate concentration at a flow rate (Qf) of 1.440 cc/h, the maximum value for a filtration fraction of ≤20%.
The results of the simulation (Fig. 1) were overlapping with the published data referring to patients with HCA with cHD during HQ-CPR.
Successful treatment of a patient with cardiac arrest due to hyperkalemia by prolonged cardiopulmonary resuscitation along with hemodialysis: A case report and review of the literature.
CRRT is less efficient than cHD with the need for an additional 23 minutes in CVVHDF and 38 minutes in CVVHD to reach a potassium concentration of 6.5 mmol/L, even with optimized parameters.
Fig. 1Predicted potassium concentration profile in the extracellular compartment with conventional hemodialysis (HD), continuous venovenous hemodiafiltration (CVVHDF) and continuous venovenous hemodialysis (CVVHD). The intersection with the dotted line represents the instant when the threshold of 6.5 mmol/L is reached with each treatment.
This simulation provides evidence to support the fact that cHD remains the standard RRT in HCA. CRRT should only be used when cHD is not available and CVVHDF (using the above optimized parameters) should be the preferred mode of therapy.
Conflicts of Interest Statement
The authors whose names are listed immediately below certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
References
Lott C.
Truhlar A.
Alfonzo A.
et al.
European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances.
Successful treatment of a patient with cardiac arrest due to hyperkalemia by prolonged cardiopulmonary resuscitation along with hemodialysis: A case report and review of the literature.
00027-8&id=gr1.jpg){kind=link}